Renal Cancer - Results from #4480

Marital status and survival in patients with renal cell carcinoma April 27, 2018

Multi-institutional analysis of CT and MRI reports evaluating indeterminate renal masses: comparison to a national survey investigating desired report elements April 27, 2018

Outcomes of pathologic stage T3a renal cell carcinoma up-staged from small renal tumor: emphasis on partial nephrectomy April 26, 2018

Phospholipase D2 promotes disease progression of renal cell carcinoma through the induction of angiogenin April 26, 2018

Vitamin D receptor suppresses proliferation and metastasis in renal cell carcinoma cell lines via regulating the expression of the epithelial Ca2+ channel TRPV5 April 26, 2018

Delayed Autoimmune Toxicity Occurring Several Months After Cessation of Anti-PD-1 Therapy April 25, 2018

Longitudinal Assessment of Vascular Function With Sunitinib in Patients With Metastatic Renal Cell Carcinoma April 25, 2018

Loss of PD-L1 (SP-142) expression characterizes renal vein tumor thrombus microenvironment in clear cell renal cell carcinoma April 25, 2018

[Management of renal cell carcinoma associated with an extensive inferior vena cava tumor thrombus] April 24, 2018

Targeted genomic landscape of metastases compared to primary tumours in clear cell metastatic renal cell carcinoma April 24, 2018

Multi-Institutional Survival Analysis of Incidental Pathologic T3a Upstaging in Clinical T1 Renal Cell Carcinoma Following Partial Nephrectomy April 23, 2018

Prognostic Value of Baseline Serum C-Reactive Protein Level in Intermediate-Risk Group Patients With Metastatic Renal-Cell Carcinoma Treated by First-Line Vascular Endothelial Growth Factor-Targeted Therapy April 23, 2018

Multi-regional Sequencing Elucidates the Evolution of Clear Cell Renal Cell Carcinoma April 23, 2018

Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal April 23, 2018

Association of Expression Levels or Activation Status of STAT3 with Treatment Outcomes of Sunitinib in Patients with Renal Cell Carcinoma April 20, 2018

Evaluation of programmed cell death protein 1 (PD-1) expression as a prognostic biomarker in patients with clear cell renal cell carcinoma April 20, 2018

Imaging and Management of Intrathoracic Renal Cell Carcinoma Metastases April 20, 2018

Immune consequences of anti-angiogenic therapyin renal cell carcinoma April 20, 2018

Presurgical pazopanib for renal cell carcinoma with inferior vena caval thrombus: a single-institution study April 19, 2018

Identifying the use and barriers to the adoption of renal tumour biopsy in the management of small renal masses April 19, 2018

Page 225 of 456